Imunon, Inc. Relocates Principal Executive Offices
Ticker: IMNN · Form: 8-K · Filed: May 22, 2025 · CIK: 749647
Sentiment: neutral
Topics: address-change, operations
TL;DR
IMUN just moved its HQ to Lawrenceville, NJ. New address: 997 Lenox Drive, Suite 100.
AI Summary
On May 22, 2025, Imunon, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648. This move is part of the company's ongoing operations and reporting requirements.
Why It Matters
This filing signals a physical operational change for Imunon, Inc., potentially impacting logistics, employee location, and investor perception of company activity.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a change in business address and does not involve financial transactions or significant operational shifts.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648 (location) — New principal executive offices address
- Delaware (jurisdiction) — State of incorporation
- 001-15911 (identifier) — Commission File Number
FAQ
What is the new address for Imunon, Inc.'s principal executive offices?
The new address for Imunon, Inc.'s principal executive offices is 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 22, 2025.
What is the Commission File Number for Imunon, Inc.?
The Commission File Number for Imunon, Inc. is 001-15911.
In which state is Imunon, Inc. incorporated?
Imunon, Inc. is incorporated in Delaware.
What type of SEC filing is this?
This is a Form 8-K, a Current Report.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Imunon, Inc. (IMNN).